Cosmeticlawinfo database

In order to strengthen the supervision and administration of cosmetics and to standardize the monitoring and assessment of cosmetic safety risks, the National Medical Products Administration (NMPA) has formulated the Measures for the Administration of Cosmetic Safety Risk Monitoring and Assessment in accordance with the Regulations on the Supervision and Administration of Cosmetics and other relevant laws and regulations. These Measures are hereby promulgated and shall come into effect on August 1, 2025. The term "risk monitoring and assessment" as used in these Measures refers to the activities carried out by drug regulatory authorities to monitor risk factors that may affect the quality and safety of cosmetics, and to analyze, evaluate, and effectively respond to the identified risks. The purpose of risk monitoring and assessment is to identify and prevent quality and safety risks associated with cosmetics, and to provide scientific evidence for the development of risk control measures and cosmetic standards, for conducting sampling inspections of cosmetics, and for facilitating the exchange and early warning of cosmetic safety risk information.